Commentary on Sawangjit et al. (2017): there is still much to be determined before policy makers can choose pharmacy needle and syringe programmes (NSP) confidently over other models of NSP provision

Research output: Contribution to journalComment/debate

LanguageEnglish
Pages248-249
Number of pages2
JournalAddiction
Volume112
Issue number2
DOIs
StatusPublished - 1 Feb 2017

Keywords

  • Blood borne viruses
  • coverage
  • injecting risk
  • needle and syringe programme
  • opiate substitution theraphy
  • pharmacy

Cite this

@article{9b783b20cf71402fb3376df6ddb4264e,
title = "Commentary on Sawangjit et al. (2017): there is still much to be determined before policy makers can choose pharmacy needle and syringe programmes (NSP) confidently over other models of NSP provision",
keywords = "Blood borne viruses, coverage, injecting risk, needle and syringe programme, opiate substitution theraphy, pharmacy",
author = "Jenny Scott",
year = "2017",
month = "2",
day = "1",
doi = "10.1111/add.13647",
language = "English",
volume = "112",
pages = "248--249",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Commentary on Sawangjit et al. (2017)

T2 - Addiction

AU - Scott,Jenny

PY - 2017/2/1

Y1 - 2017/2/1

KW - Blood borne viruses

KW - coverage

KW - injecting risk

KW - needle and syringe programme

KW - opiate substitution theraphy

KW - pharmacy

UR - http://www.scopus.com/inward/record.url?scp=85008975678&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1111/add.13647

U2 - 10.1111/add.13647

DO - 10.1111/add.13647

M3 - Comment/debate

VL - 112

SP - 248

EP - 249

JO - Addiction

JF - Addiction

SN - 0965-2140

IS - 2

ER -